- Home
- GHRS vs CPAC Comparison
GHRS vs CPAC Comparison
Compare GHRS & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | CPAC |
|---|---|---|
| Founded | 2018 | 1949 |
| Country | Ireland | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 905.9M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | GHRS | CPAC |
|---|---|---|
| Price | $16.49 | $10.95 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 10 | 2 |
| Target Price | ★ $32.00 | $10.15 |
| AVG Volume (30 Days) | ★ 673.8K | 29.0K |
| Earning Date | 02-26-2026 | 02-13-2026 |
| Dividend Yield | N/A | ★ 5.08% |
| EPS Growth | N/A | ★ 20.27 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $601,081,883.00 |
| Revenue This Year | N/A | $9.96 |
| Revenue Next Year | N/A | $1.70 |
| P/E Ratio | ★ N/A | $14.01 |
| Revenue Growth | N/A | ★ 6.18 |
| 52 Week Low | $7.98 | $5.10 |
| 52 Week High | $20.50 | $11.30 |
Technical Indicators
Market Signals| Indicator | GHRS | CPAC |
|---|---|---|
| Relative Strength Index (RSI) | 59.57 | 66.42 |
| Support Level | $15.48 | $10.22 |
| Resistance Level | $17.30 | $11.03 |
| Average True Range (ATR) | 1.64 | 0.37 |
| MACD | 0.14 | -0.07 |
| Stochastic Oscillator | 60.55 | 85.28 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.